Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal

11 months ago

Bristol Myers Squibb said it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash. 

More Stories

European tech CEOs urge ‘Europe-first’ mentality to counter U.S. dominance after Trump victory

30 mins ago

Sri Lanka leader reappoints Amarasuriya as PM, retains finance and defence

31 mins ago

Ukraine’s Zelenskyy says US long-range missiles will ‘speak for themselves’

2 hours ago

Leave a Reply

Your email address will not be published. Required fields are marked *

You may have missed

Linkage Assurance, C & I Leasing, Fidson top stock pick this week

30 mins ago

Surely, we cannot inflate our way to growth, By Uddin Ifeanyi

30 mins ago

NPBL Final Eight: Rivers Hoopers, Hoops & Read set for championship showdown

30 mins ago

Igali reiterates commitment to development of wrestling throughout Nigeria

30 mins ago

Every DP World Tour winner this season

30 mins ago